Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: A case report and review of literature

Clinical Rheumatology

Volumn 30, Issue 2, 2011, Pages 293-300

  Wink, Freke ^a   Houtman, Pieternella M ^a   Jansen, Tim L Th A ^b  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti CD20 antibody; Cryoglobulin; Cryoglobulinaemic vasculitis; Rituximab

Indexed keywords

AZATHIOPRINE; CRYOGLOBULIN; IMMUNOGLOBULIN M; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; RHEUMATOID FACTOR; RITUXIMAB;

AGED; ANAMNESIS; BONE MARROW BIOPSY; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRYOGLOBULINEMIA; FEMALE; HUMAN; KIDNEY BIOPSY; LABORATORY TEST; MUSCLE BIOPSY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; TREATMENT RESPONSE; VASCULITIS;

AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CRYOGLOBULINEMIA; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; REMISSION INDUCTION; TREATMENT OUTCOME; VASCULITIS;

EID: 79954440147     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1612-2     Document Type: Review

References (39)

1. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M (1974) Biological and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 57:775-788.
2. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N (1966) Cryoglobulinemia: a clinical and laboratory study. Am J Med 40(6):837-856.
3. Lamprecht P, Gause A, Gross WL (1999) Cryoglobulinemic vasculitis. Arthritis Rheum 42(12):2507-2516. (Pubitemid 30327166)
4. Plosker GL, Figgitt DP (2003) Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs 63(8):803-843. (Pubitemid 36432084)
5. Leandro MJ, Edwards JC, Cambridge G (2002) Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheum Dis 61:883-888.
6. Higashida J, Wun T, Schmidt S, Naguwa SM, Tuscano JM (2005) Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment. J Rheumatol 32 (11):2109-2115. (Pubitemid 41587853)
7. Nehme-Schuster H, Korganow AS, Pasquali JL, Martin T (2005) Rituximab inefficiency during type I cryolobulinaemia. Rheumatology (Oxford) 44(3):410-411.
8. Cohen H, Green S, Jones S, Amos N, William BD (2007) Lack of efficacy of rituximab in a patient with essential mixed cryoglobulinaemia. Rheumatology 46:366-367. (Pubitemid 46189804)
9. Roccatello D, Baldovino S, Rossi D, Giachino O, Mansouri M(2008) Rituximab as a therapeutic tool in severe mixed cryoglobulinemia. Clin Rev Allergy Immunol 34:111-117.
10. Zaja F, De Vita S, Mazzaro C, Sacco S, Damiani D (2003) Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101:3827-3834. (Pubitemid 36857853)
11. Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F (2003) Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon α with an anti-CD20. Blood 101:3818-3826. (Pubitemid 36857852)
12. Sène D, Ghillani-Dalbin P, Amoura Z, Musset L, Cacoub P (2009) Rituximab may form a complex with IgMκ mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis. Arthritis Rheum 60(12):3848-3855.
13. Bryce AH, Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV (2006) Response to rituximab in patients with type II cryoglobulinemia. Clin Lymphoma Meyloma 7(2):140-144. (Pubitemid 44596597)
14. Arzoo K, Sadeghi S, Liebman HA (2006) Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab). Ann Rheum Dis 61:922-924.
15. Koukoulaki M, Abeygunasekara SM, Smith KGC, Jayne DRW (2005) Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab. Nephrol Dial Transplant 20:213-216. (Pubitemid 40207630)
16. Rego TCG, Massumoto CM, Batista RS, De Moura LH, Soares LMC, Gomes AP (2007) The use of monoclonal antibody (rituximab) in the treatment of type II mixed cryoglobulinemia. Braz J Infect Dis 11(1):174-175. (Pubitemid 47024120)
17. Lamprecht P, Lerin-Lozano C, Merz H, Dennin RH, Gause A, Voswinkel J, Peters SA, Gutzeit O, Arlt AC, Solbach W, Gross WL (2003) Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann Rheum Dis 62:1230-1233. (Pubitemid 37500635)
18. Ruch J, McMahon B, Ramsey G, Kwaan HC (2009) Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab. Am J Hematol 84:120-122.
19. Pekow J, Chung RT (2006) Treatment of type II cryoglobulinemia associated with hepatitis C with rituximab. J Clin Gastroenterol 40 (5):450. (Pubitemid 44318169)
20. Ghijsels E, Lerut E, Vanrenterghem Y, Kuypers D (2004) Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure. Am J Kidney Dis 43(5):e34-e38.
21. Braun A, Neumann T, Oelzner P, Hein G, Gröne HJ, Ziemer M, Wolf G (2008) Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab. Rheumatol Int 28:503-506. (Pubitemid 351629481)
22. Cai FZJ, Ahern M, Smith M (2006) Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab. J Rheumatol 33 (6):1197-1198. (Pubitemid 43825478)
23. Massari M, Catania A, Magnani G (2007) Efficacy and risk of rituximab in type II mixed cryoglobulinemia: a significant case report. Dig Liver Dis 39(suppl 1):S134-S135. (Pubitemid 47610324)
24. Pandrangi S, Singh A, Wheeler DE, Rossi NF (2008) Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis. Nat Clin Pract Nephrol 4(7):393-397. (Pubitemid 351913687)
25. Evans JT, Shepard MM, Oates JC, Self SE, Reuben A (2008) Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis. J Clin Gastroenterol 42(7):862-863.
26. Pasa S, Altintas A, Cil T, Danis R, Ayyildiz O, Muftuoglu E (2009) A case of essential mixed cryoglobulinemia and associated acquired von-Willebrand disease treated with rituximab. J Thromb Thrombolysis 27:220-222.
27. Basse G, Ribes D, Kamar N, Mehrenberger M, Esposito L, Guitard J (2005) Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients. Transplantation 80:1560- 1564. (Pubitemid 43005866)
28. Visenti M, Granata M, Veneziano ML, Borghese F, Carlesimo M, Pimpinelli F, Fiorilli M, Casato M (2007) Efficacy of low-dose rituximab for mixed cryoglobulinemia. Clin Immunol 125:30-33. (Pubitemid 47374540)
29. Cavallo R, Roccatello D, Menegatti E, Naretto C, Napoli F, Baldovino S (2009) Rituximab in cryoglobulinemic peripheral neuropathy. J Neurol 256:1076-1082.
30. Saadoun D, Resche-Rigon M, Sene D, Perard L, Piette JC, Cacoub P (2008) Rituximab combined with peg-interferonribavirin in refractory HCV-associated cryoglobulinemia vasculitis. Ann Rheum Dis 67(10):1431-1436.
31. Catuogno M, Rezai S, Priori S, Magrini L, Valesini G (2005) Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinemia. Rheumatology 44:406. (Pubitemid 40361306)
32. Quartuccio L, Soardo G, Romano G, Zaja F, Scott CA, De Marchi G, Fabris M, Ferraccioli G, De Vita S (2006) Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroid. Rheumatology 45:842-846. (Pubitemid 43985372)
33. Korte MR, van Heerde MJ, de Man RA, Betjes MHG (2008) Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia. Neth J Med 66(1):27-30. (Pubitemid 351188287)
34. Uppal R, Charles E, Lake-Bakaar G (2009) Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab. J Clin Virol 47(1):69-71.
35. Zaja F, De Vita S, Russo D, Michelutti A, Fanin R, Ferraccioli G, Baccarani M (2002) Rituximab for the treatment of type II mixed cryoglobulinemia. Arthritis Rheum 46(8):2252-2254.
36. Zaja F, Russo D, Patriarca F, Ermacora A, Baccarani M (1999) Rituximab for the treatment of type II mixed cryoglobulinemia. Haematologica 84(12):1157-1158. (Pubitemid 30016593)
37. Silverman GJ, Weisman S (2003) Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum 48(6):1484-1492. (Pubitemid 36682354)
38. Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P, Watier H (2002) Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene. Blood 99(3):754-758. (Pubitemid 34525533)
39. Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D (2008) Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: where do we stand? Ann Rheum Dis 67 (3):283-287. (Pubitemid 351281259)